Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.34 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | ELANE | P08246 | 2/20 | 0.32 |
| ▸ | KDM1A | O60341 | 6/20 | 0.31 |
| ▸ | MAOA | P21397 | 6/20 | 0.31 |
| ▸ | MAOB | P27338 | 6/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | CNR1 | P21554 | 1/20 | 0.31 |
| ▸ | GPR55 | Q9Y2T6 | 1/20 | 0.31 |
| ▸ | PGR | P06401 | 1/20 | 0.30 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29728008 | 1.00 | CYP1A2 (0.34) | CYP1A2CYP2C19KMT2AALDH1A1KDM4E | |
| SCHEMBL10901108 | 0.82 | KDM1A (0.35) | CYP1A2CYP2C19KMT2AKDM4EKDM1A | |
| SCHEMBL15071292 | 0.78 | ALDH1A1 (0.34) | CYP1A2CYP2C19KMT2AALDH1A1ELANE | |
| SCHEMBL6872631 | 0.76 | ALDH1A1 (0.41) | CYP1A2CYP2C19KMT2AALDH1A1KDM4E | |
| SCHEMBL15069963 | 0.73 | ALDH1A1 (0.32) | ALDH1A1ELANE | |
| SCHEMBL18217969 | 0.73 | PKM (0.33) | ALDH1A1ELANEPKM | |
| SCHEMBL1297947 | 0.70 | ELANE (0.46) | CYP2C19ALDH1A1ELANE | |
| SCHEMBL564222 | 0.69 | NOTUM (0.36) | KMT2AALDH1A1KDM4EHPGD | |
| SCHEMBL12106926 | 0.69 | RXRA (0.33) | KMT2AALDH1A1KDM4EMAOAMAOB | |
| SCHEMBL4988366 | 0.67 | CYP2B6 (0.39) | CYP2C19ALDH1A1ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3458522-B1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM SPA (IT) | 2024-01-03 | — | — | EP | claimed |
| US-10723710-B2 | Process for the preparation of diaminophenothiazinium compounds having a high degree of purity | ICROM S.P.A. (IT) | 2020-07-28 | — | — | US | claimed |
| US-20190185440-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM S.P.A. (IT) | 2019-06-20 | — | — | US | claimed |
| US-9856364-B2 | Stabilized reversible polymer composition | XEROX CORPORATION (US) | 2018-01-02 | — | — | US | claimed |
| US-20140353549-A1 | STABILIZED REVERSIBLE POLYMER COMPOSITION | XEROX CORPORATION (US) | 2014-12-04 | — | — | US | claimed |
| US-8349961-B2 | Process for the preparation of high impact vinylaromatic (co)polymers grafted on an elastomer | POLIMERI EUROPA S.P.A. (IT) | 2013-01-08 | — | — | US | claimed |
| EP-0845448-B1 | Inhibiting polymerization of vinyl aromatic monomers | ONDEO NALCO ENERGY SERV LP (US) | 2002-01-30 | — | — | EP | claimed |
| EP-0845448-A1 | Inhibiting polymerization of vinyl aromatic monomers | Ciba SC Holding AG (CH) | 1998-06-03 | — | — | EP | claimed |
| EP-0717054-A2 | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1996-06-19 | — | — | EP | claimed |
| US-5449724-A | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1995-09-12 | — | — | US | claimed |
| US-20240117121-A1 | MULTIFUNCTIONAL NITROXIDE-MEDIATED POLYMERIZATION INITIATORS AND MULTI-ARMED POLYMERS AND HYDROGELS FORMED THEREFROM | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2024-04-11 | — | — | US | disclosed |
| EP-3458522-B1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | ICROM SPA (IT) | 2024-01-03 | — | — | EP | disclosed |
| US-11820868-B2 | Multifunctional nitroxide-mediated polymerization initiators and multi-armed polymers and hydrogels formed therefrom | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2023-11-21 | — | — | US | disclosed |
| US-11814336-B2 | Oligomeric alkoxy amines | ARKEMA FRANCE (FR) | 2023-11-14 | — | — | US | disclosed |
| US-20210139415-A1 | OLIGOMERIC ALKOXYAMINES | ARKEMA FRANCE (FR) | 2021-05-13 | — | — | US | disclosed |
| EP-0717054-A2 | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1996-06-19 | — | — | EP | disclosed |
| US-5449724-A | Stable free radical polymerization process and thermoplastic materials produced therefrom | XEROX CORPORATION (US) | 1995-09-12 | — | — | US | disclosed |
| EP-0135280-B1 | NEW POLYMERIZATION PROCESS AND POLYMERS PRODUCED THEREBY | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1993-05-12 | — | — | EP | disclosed |
| US-4581429-A | Polymerization process and polymers produced thereby | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANIZATION (AU) | 1986-04-08 | — | — | US | disclosed |
| EP-0135280-A2 | New polymerization process and polymers produced thereby | COMMONWEALTH SCIENTIFIC AND INDUSTRIAL RESEARCH ORGANISATION (AU) | 1985-03-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10723710-B2 | Process for the preparation of diaminophenothiazinium compounds having a high degree of purity | DDT, QDPR, DDC | CYP1A2 545/4885CYP2C19 247/4885KMT2A 961/4885 |
| US-20210139415-A1 | OLIGOMERIC ALKOXYAMINES | ALKBH3, ALK, ALKBH2 | CYP1A2 2104/4885CYP2C19 3918/4885KMT2A 399/4885 |
| US-11814336-B2 | Oligomeric alkoxy amines | ALKBH3, ALK, PNMT | CYP1A2 1882/4885CYP2C19 3722/4885KMT2A 439/4885 |
| US-20190185440-A1 | PROCESS FOR THE PREPARATION OF DIAMINOPHENOTHIAZINIUM COMPOUNDS HAVING A HIGH DEGREE OF PURITY | DDT, QDPR, DDC | CYP1A2 545/4885CYP2C19 247/4885KMT2A 961/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.